Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases.

Current vascular pharmacology

Volumn 1, Issue 3, 2003, Pages 329-333

  Dey, Sujoya ^a   Mukherjee, Debabrata ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERIOSCLEROSIS; CLINICAL TRIAL; HUMAN; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; REVIEW; TREATMENT OUTCOME;

ARTERIOSCLEROSIS; CLINICAL TRIALS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 16544366485     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161033476673     Document Type: Review

References (45)